BridgeMD
New treatment option for Endometriosis
Official title Therapeutic-educational Physiotherapy on Pain, Physical-functionality and Quality of Life in Women With Endometriosis.
ClinicalTrials.gov ID: NCT06212349
What this study is testing
- What it's testing
- This is a randomized clinical trial that will be carried out in women with endometriosis divided into two groups: the experimental group (EG) that will receive therapeutic-educational physiotherapy, which will combine therapeutic exercise with a pain education program, and the control group (CG) who will receive the pain education program. The participants will be evaluated at three moments: before starting the study (T1), after the 8-week treatment program (T2) and after another 8 weeks of follow-up in which they will be encouraged to continue with the treatment (T3).
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 45, women only
You may be able to join if
- Diagnosis of endometriosis made by imaging techniques (MRI or ultrasound) or by surgery.
- A period of 3 months or more since the last surgery if they have undergone surgery.
- Who are receiving hormone treatment and have their disease under control.
- Persistent pelvic pain for at least 3 months.
- With pain and hypertonus in the pelvic musculature, myofascial syndrome, vestibulodynia or pudendal neuropathy.
You likely can't join if
- Women in the menopausal phase
- Women undergoing fertility treatment or planning to undergo fertility treatment in the next 3 months.
- Pregnant women.
- Women undergoing physiotherapy treatment or who have undergone physiotherapy treatment in the last 3 months.
- Having suffered a fracture in the last 3 months in the lower limb that limits their functional capacity.
- Cognitive illness that prevents correct comprehension of the exercises.
See the full eligibility criteria
- Diagnosis of endometriosis made by imaging techniques (MRI or ultrasound) or by surgery.
- A period of 3 months or more since the last surgery if they have undergone surgery.
- Who are receiving hormone treatment and have their disease under control.
- Persistent pelvic pain for at least 3 months.
- With pain and hypertonus in the pelvic musculature, myofascial syndrome, vestibulodynia or pudendal neuropathy.
- Consent to participate in the study
- Capable of carrying out the follow-up of the study until the final visit.
- Who have audiovisual resources and the internet at their disposal.
- Women in the menopausal phase
- Women undergoing fertility treatment or planning to undergo fertility treatment in the next 3 months.
- Pregnant women.
- Women undergoing physiotherapy treatment or who have undergone physiotherapy treatment in the last 3 months.
- Having suffered a fracture in the last 3 months in the lower limb that limits their functional capacity.
- Cognitive illness that prevents correct comprehension of the exercises.
- Musculoskeletal pathology or neuropathy in acute phase.
- Having suffered or suffering from a neoplastic disease.
- Untreated endometriosis
- Acquired genital abnormalities of the pelvis or pelvic floor.
- Women in a situation of litigation or economic compensation, or pending the granting of a degree of disability.
- Severe mental illness (schizophrenia, borderline personality disorder, etc.)
The study team makes the final eligibility decision.
Where it's taking place
- Valencia, Spain
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 45 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Valencia, Spain. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.